Literature DB >> 1419476

Ondansetron as an antiemetic.

M D Reed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419476      PMCID: PMC1381531     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  Ondansetron. Therapeutic use as an antiemetic.

Authors:  R J Milne; R C Heel
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

2.  Is ondansetron a less effective antiemetic against moderately emetic as compared with highly emetic chemotherapy?

Authors:  J W Dundee; C M McMillan; J Yang; P M Wright
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

3.  Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.

Authors:  G Fraschini; A Ciociola; L Esparza; D Templeton; F A Holmes; R S Walters; G N Hortobagyi
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

4.  Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.

Authors:  S M Grunberg; L L Stevenson; C A Russell; J E McDermed
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

  4 in total
  1 in total

Review 1.  Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Authors:  G L Plosker; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.